Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration

[1]  Li Yang,et al.  Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[2]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[3]  Taojiao Wang,et al.  Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.

[4]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[5]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[6]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[7]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[8]  G. Yamanaka,et al.  Brain-Derived Neurotrophic Factor and Interleukin-6 Levels in the Serum and Cerebrospinal Fluid of Children with Viral Infection-Induced Encephalopathy , 2014, Neurochemical Research.

[9]  A. Karni,et al.  Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection , 2008, Journal of Neuroimmunology.

[10]  A. Karni,et al.  Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate , 2005, Journal of Neuroimmunology.

[11]  H. Scharfman,et al.  Mini Review , 2004 .

[12]  M. Riva,et al.  Cellular Neuroscience Mini Review Article Brain-derived Neurotrophic Factor: a Bridge between Inflammation and Neuroplasticity , 2022 .